Frank Montgomery

Frank Montgomery is the Vice President of CMC Regulatory Affairs at AstraZeneca, a position they have held since 2022. With extensive experience in the pharmaceuticals industry, they have previously served as Global Head of Regulatory CMC, overseeing synthetic molecules, biologics, devices, and digital therapeutics. Frank has a strong foundation in regulatory requirements and quality by design, supported by a PhD in Organic Chemistry from Imperial College London and post-doctoral research in Synthetic Organic Chemistry from The Ohio State University.